Elaine Katrivanos

Elaine Katrivanos currently serves as Vice President of Regulatory Affairs at Tempus AI, a position held since May 2020, and also contributes as Co-Chair of the Global Regulatory Working Group at BLOODPAC since 2022. Prior experience includes roles at AstraZeneca as Director of Global Regulatory Affairs Strategy and an extensive tenure at the FDA, where responsibilities included Program Policy Manager in the Office of In Vitro Diagnostics and Radiological Health, Branch Chief for Obstetrics and Gynecology Devices, and various positions as Biomedical Engineer and Scientific Reviewer. Earlier in the career, Elaine worked as a Bioengineering Student Researcher at the University of Pittsburgh. Academic qualifications include degrees from The George Washington University School of Business and the University of Pittsburgh Swanson School of Engineering.